Literature DB >> 22183031

Morphological changes and oxidative damage in Rett Syndrome erythrocytes.

Lucia Ciccoli1, Claudio De Felice, Eugenio Paccagnini, Silvia Leoncini, Alessandra Pecorelli, Cinzia Signorini, Giuseppe Belmonte, Giuseppe Valacchi, Marcello Rossi, Joussef Hayek.   

Abstract

BACKGROUND: Hypoxemia and increased oxidative stress (OS) have been reported in Rett Syndrome (RTT), a genetical neurodevelopmental disorder. Although OS and hypoxemia can lead to red blood cells (RBCs) shape abnormalities, no information on RBCs morphology in RTT exists. Here, RBCs shape was evaluated in RTT patients and healthy subjects as a function of OS markers, blood oxygenation, pulmonary gas exchange, and cardio-respiratory parameters.
METHODS: RBCs morphology was evaluated by Scanning Electron Microscopy. Intraerythrocyte and plasma non protein-bound iron (NPBI), esterified F(2)-Isoprostanes (F(2)-IsoPs), 4-HNE protein adducts (4-HNE PAs) were measured. Pulmonary oxygen gradients and PaO(2) were evaluated by gas analyzers and cardiopulmonary variables by pulse oximetry. In RTT patients these parameters were assessed before and after ω-3 polyunsaturated fatty acids (ω-3 PUFAs) administration.
RESULTS: Altered RBCs shapes (leptocytes) and increased NPBI were present in RTT, together with increased erythrocyte membrane esterified F(2)-IsoPs and 4-HNE PAs. Abnormal erythrocyte shapes were related to OS markers levels, pulmonary gas exchange, PaO(2) and cardio-respiratory variables. After ω-3 PUFAs, a decrease of leptocytes was accompanied by a progressive increase in reversible forms of RBCs. This partial RBCs morphology rescue was related to decreased OS damage markers, improved pulmonary oxygen exchange, and cardiopulmonary physiology.
CONCLUSIONS: These findings indicate that in RTT 1) RBCs shape is altered; 2) the OS-hypoxia diad is critical in generating altered RBCs shape and membrane damage; 3) ω-3 PUFAs are able to partially rescue RBCs morphology and the OS-derived damage. GENERAL SIGNIFICANCE: RBCs morphology is an important biosensor for OS imbalance and chronic hypoxemia.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22183031     DOI: 10.1016/j.bbagen.2011.12.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

1.  Mitochondrial Electron Transport Chain Complex Dysfunction in MeCP2 Knock-Down Astrocytes: Protective Effects of Quercetin Hydrate.

Authors:  Arpita Dave; Foram Shukla; Hemendra Wala; Prakash Pillai
Journal:  J Mol Neurosci       Date:  2018-12-06       Impact factor: 3.444

2.  Oxygen exchange and energy metabolism in erythrocytes of Rett syndrome and their relationships with respiratory alterations.

Authors:  Chiara Ciaccio; Donato Di Pierro; Diego Sbardella; Grazia Raffaella Tundo; Paolo Curatolo; Cinzia Galasso; Marta Elena Santarone; Maurizio Casasco; Paola Cozza; Alessio Cortelazzo; Marcello Rossi; Claudio De Felice; Joussef Hayek; Massimo Coletta; Stefano Marini
Journal:  Mol Cell Biochem       Date:  2017-01-07       Impact factor: 3.396

3.  Inflammatory protein response in CDKL5-Rett syndrome: evidence of a subclinical smouldering inflammation.

Authors:  Alessio Cortelazzo; Claudio de Felice; Silvia Leoncini; Cinzia Signorini; Roberto Guerranti; Roberto Leoncini; Alessandro Armini; Luca Bini; Lucia Ciccoli; Joussef Hayek
Journal:  Inflamm Res       Date:  2016-11-29       Impact factor: 4.575

4.  Effects of oral administration of common antioxidant supplements on the energy metabolism of red blood cells. Attenuation of oxidative stress-induced changes in Rett syndrome erythrocytes by CoQ10.

Authors:  Donato Di Pierro; Chiara Ciaccio; Diego Sbardella; Grazia Raffaella Tundo; Roberta Bernardini; Paolo Curatolo; Cinzia Galasso; Virginia Pironi; Massimiliano Coletta; Stefano Marini
Journal:  Mol Cell Biochem       Date:  2019-10-08       Impact factor: 3.396

5.  Cytokine Dysregulation in MECP2- and CDKL5-Related Rett Syndrome: Relationships with Aberrant Redox Homeostasis, Inflammation, and ω-3 PUFAs.

Authors:  Silvia Leoncini; Claudio De Felice; Cinzia Signorini; Gloria Zollo; Alessio Cortelazzo; Thierry Durand; Jean-Marie Galano; Roberto Guerranti; Marcello Rossi; Lucia Ciccoli; Joussef Hayek
Journal:  Oxid Med Cell Longev       Date:  2015-07-08       Impact factor: 6.543

6.  Inflammatory lung disease in Rett syndrome.

Authors:  Claudio De Felice; Marcello Rossi; Silvia Leoncini; Glauco Chisci; Cinzia Signorini; Giuseppina Lonetti; Laura Vannuccini; Donatella Spina; Alessandro Ginori; Ingrid Iacona; Alessio Cortelazzo; Alessandra Pecorelli; Giuseppe Valacchi; Lucia Ciccoli; Tommaso Pizzorusso; Joussef Hayek
Journal:  Mediators Inflamm       Date:  2014-03-17       Impact factor: 4.711

7.  Erythrocyte shape abnormalities, membrane oxidative damage, and β-actin alterations: an unrecognized triad in classical autism.

Authors:  Lucia Ciccoli; Claudio De Felice; Eugenio Paccagnini; Silvia Leoncini; Alessandra Pecorelli; Cinzia Signorini; Giuseppe Belmonte; Roberto Guerranti; Alessio Cortelazzo; Mariangela Gentile; Gloria Zollo; Thierry Durand; Giuseppe Valacchi; Marcello Rossi; Joussef Hayek
Journal:  Mediators Inflamm       Date:  2013-12-21       Impact factor: 4.711

8.  Beta-actin deficiency with oxidative posttranslational modifications in Rett syndrome erythrocytes: insights into an altered cytoskeletal organization.

Authors:  Alessio Cortelazzo; Claudio De Felice; Alessandra Pecorelli; Giuseppe Belmonte; Cinzia Signorini; Silvia Leoncini; Gloria Zollo; Antonietta Capone; Cinzia Della Giovampaola; Claudia Sticozzi; Giuseppe Valacchi; Lucia Ciccoli; Roberto Guerranti; Joussef Hayek
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

9.  A plasma proteomic approach in Rett syndrome: classical versus preserved speech variant.

Authors:  Alessio Cortelazzo; Roberto Guerranti; Claudio De Felice; Cinzia Signorini; Silvia Leoncini; Alessandra Pecorelli; Claudia Landi; Luca Bini; Barbara Montomoli; Claudia Sticozzi; Lucia Ciccoli; Giuseppe Valacchi; Joussef Hayek
Journal:  Mediators Inflamm       Date:  2013-12-23       Impact factor: 4.711

Review 10.  Isoprostanes and 4-hydroxy-2-nonenal: markers or mediators of disease? Focus on Rett syndrome as a model of autism spectrum disorder.

Authors:  Cinzia Signorini; Claudio De Felice; Thierry Durand; Camille Oger; Jean-Marie Galano; Silvia Leoncini; Alessandra Pecorelli; Giuseppe Valacchi; Lucia Ciccoli; Joussef Hayek
Journal:  Oxid Med Cell Longev       Date:  2013-06-13       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.